Furthermore, compared with AD model cells, cotreatment of PELI1 siRNA with Aβ increased Traf3 expression and decreased phosphorylation levels of ERK1/2 and P38 both in BV-2 and HT22 cells. The gene discussed is PELI1; the disease is Alzheimer disease.